← Back to Search

Health Technology to Improve Exercise in Ankylosing Spondylitis

N/A
Recruiting
Led By Laura Passalent
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults (aged 18 and older) with a diagnosis of axSpA based on ASAS criteria
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed electronically by an e-survey platform at baseline, 3, 6, 9 and 12 weeks in the intervention and control groups.
Awards & highlights

Study Summary

This trial will test how using tech like smartphone apps to educate people with axial spondyloarthritis on physical activity can improve their quality of life.

Who is the study for?
This trial is for adults over 18 with axial spondyloarthritis (axSpA) who are part of the SPARCC Research Program. Participants must pass a health screen, have access to email and a smartphone, and be able to engage in physical activity without restrictions from other serious health issues.Check my eligibility
What is being tested?
The study aims to develop and test a strategy using health technology like smartphone apps and emails to encourage regular exercise among axSpA patients. The goal is for participants to increase daily physical activity, which may improve symptoms and quality of life.See study design
What are the potential side effects?
Since this intervention involves non-medical technology use aimed at increasing exercise, side effects are not typical as with drug trials but may include general discomfort or injury related to new physical activities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an adult diagnosed with axial spondyloarthritis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed electronically by an e-survey platform at baseline, 3, 6, 9 and 12 weeks in the intervention and control groups.
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed electronically by an e-survey platform at baseline, 3, 6, 9 and 12 weeks in the intervention and control groups. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in functioning and health as a result of the technology-based intervention strategy as measured by the ASAS Health Index
Change in levels of physical activity as measured by Accelerometry
Change in perceived benefits and barriers to exercise as a result of the technology-based intervention strategy as measured by the Exercise Benefits/Barriers Scale (EBBS)
+2 more
Secondary outcome measures
Acceptance of health technology-based intervention strategy, as measured by the Mobile Application Rating Scale
Disease
Change in function over the course of 12 weeks as measured by the Bath Ankylosing Spondylitis Functional Index (BASFI) questionnaire
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Participants randomized to the intervention group will receive an initial electronic communication (i.e. email) that includes: Link to physical activity education. This will be an educational module based on Phase 1 results and evidence-based literature regarding the benefits of physical activity in the general population and specific to axSpA. One week after receiving the physical activity educational module, participants will receive access to the ADAS application and an .ics file for each 3-week cycle of electronic calendar reminders to engage in physical activity.
Group II: Control GroupActive Control1 Intervention
Participants randomized to the control group will receive usual care, which includes standard rheumatology care and access to educational materials on the importance of exercise and physical activity available through the TWH Spondylitis Program and through the public domain. They will receive a link to the physical activity educational module at baseline. They also have access to the program physiotherapist for a single one-hour individualized exercise consultation as requested by either the patient or the treating rheumatologist.

Find a Location

Who is running the clinical trial?

Canadian Initiative for Outcomes in Rheumatology CareOTHER
5 Previous Clinical Trials
435 Total Patients Enrolled
University Health Network, TorontoLead Sponsor
1,464 Previous Clinical Trials
483,495 Total Patients Enrolled
Laura PassalentPrincipal InvestigatorUniversity Health Network, Toronto

Media Library

Health technology-based intervention strategy Clinical Trial Eligibility Overview. Trial Name: NCT05504616 — N/A
Ankylosing Spondylitis Research Study Groups: Control Group, Intervention Group
Ankylosing Spondylitis Clinical Trial 2023: Health technology-based intervention strategy Highlights & Side Effects. Trial Name: NCT05504616 — N/A
Health technology-based intervention strategy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05504616 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What aims are being pursued with this experimental research?

"This clinical trial will measure its progress over a twelve-week period, with the primary goal being to evaluate changes in physical activity among participants through the International Physical Activity Questionnaire-Short Form questionnaire (IPAQ-SF). Additionally, secondary outcomes include alterations in disease severity using the Bath Ankylosing spondylitis Disease Activity Index (BASDI) questionnaire and assessing patient acceptance of technology based interventions by way of Mobile Application Rating Scale."

Answered by AI

How many participants is the clinical trial recruiting?

"Affirmative. Data hosted on clinicaltrials.gov certify that this medical experiment, which was originally posted on July 21st 2022, is presently enrolling participants. Approximately 106 individuals must be recruiter from a single facility."

Answered by AI

Is participation in this clinical trial still an option for potential volunteers?

"Affirmative. The data hosted on clinicaltrials.gov demonstrates that enrollment is still ongoing for this medicinal research, which was initially posted on July 21st 2022 and recently changed on November 2nd 2022. 106 individuals need to be brought into the study from 1 centre."

Answered by AI

Who else is applying?

What state do they live in?
Oregon
What portion of applicants met pre-screening criteria?
Did not meet criteria
~40 spots leftby Mar 2025